Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25–35) are dependent on stimulation-protocol and genetic background

@article{Gengler2006ImpairmentsOH,
  title={Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25–35) are dependent on stimulation-protocol and genetic background},
  author={Simon Gengler and Victor A. Gault and Patrick Harriott and Christian H{\"o}lscher},
  journal={Experimental Brain Research},
  year={2006},
  volume={179},
  pages={621-630}
}
The aggregation of beta-amyloid to plaques in the brain is one of the hallmarks of Alzheimer disease (AD). Numerous studies have tried to elucidate to what degree amyloid peptides play a role in the neurodegenerative developments seen in AD. While most studies report an effect of amyloid on neural activity and cognitive abilities of rodents, there have been many inconsistencies in the results. This study investigated to what degree the different genetic backgrounds affect the outcome of beta… 
Beta‐amyloid protein (25–35) disrupts hippocampal network activity: Role of Fyn‐kinase
TLDR
The data suggest that βAP acutely affects proper hippocampal function through a Fyn‐dependent mechanism, and proposes that such alteration might be related to the cognitive impairment observed, at least, during the early phases of Alzheimer's disease.
β-Amyloid 25–35 Suppresses the Secretory Activity of the Dopaminergic System in the Rat Brain
TLDR
Dopamine release in the dorsomedial striatum was decreased during the first hour after β-amyloid administration, and no statistically significant changes in the core and shell of the nucleus accumbens were seen.
Colivelin ameliorates amyloid β peptide‐induced impairments in spatial memory, synaptic plasticity, and calcium homeostasis in rats
TLDR
Results indicate that CLN has significant neuroprotective properties against Aβ, and CLN may holds great promise for the treatment and prevention of AD.
Role of Amyloid-β Glycine 33 in Oligomerization, Toxicity, and Neuronal Plasticity
TLDR
The findings reveal that conformational changes induced by G33 substitutions unlink toxicity and oligomerization of A β on the molecular level and suggest that G33 is the key amino acid in the toxic activity of Aβ.
β-Amyloid and Lithium Affect the Magnitude of Phasic Dopamine Release in the Shell of the Nucleus Accumbens
TLDR
Increases in stimulated dopamine release provided evidence that during the 1.5 h after administration of both β-amyloid and lithium, the ability of ventral tegmental area neurons to secret dopamine in the shell of the nucleus accumbens was increased.
...
...

References

SHOWING 1-10 OF 69 REFERENCES
Generation of Aggregated β-Amyloid in the Rat Hippocampus Impairs Synaptic Transmission and Plasticity and Causes Memory Deficits
TLDR
It is suggested that aggregated amyloid material induces cognitive deficits similar to those observed in the early phases of Alzheimer's disease via an alteration in neuronal transmission and plasticity.
Block of LTP in rat hippocampus in vivo by β‐amyloid precursor protein fragments
TLDR
Dosing of β-amyloid precursor protein fragments 1–40 and 1–42 and the C-terminal fragment CT105 greatly shortened the duration of high frequency stimulation-induced long-term potentiation (LTP) of field excitatory postsynaptic potentials in the CA1 area, contributing to the cognitive deficits in Alzheimer's disease.
Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments.
TLDR
Doses of beta-amyloid precursor protein fragments greatly shortened the duration of high frequency stimulation-induced long-term potentiation (LTP) of field excitatory postsynaptic potentials in the CA1 area and may contribute to the cognitive deficits in Alzheimer's disease.
Lack of alzheimer pathology after β-amyloid protein injections in rat brain
Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.
TLDR
The primary and secondary structures of beta-amyloid that are involved in its in vitro assembly into neurotoxic peptide aggregates are defined and may underlie both its pathological deposition and subsequent degenerative effects in Alzheimer's disease.
β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation
TLDR
Findings elucidate molecular mechanisms of neuronal injury in AD and suggest that antiinflammatory compounds preventing activation of p38 MAPK in microglia may reduce neuronal vulnerability in AD.
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
TLDR
The biochemical isolation of discrete amyloid-β moieties with pathophysiological properties sets the stage for a new approach to studying the molecular mechanisms of cognitive impairment in Alzheimer disease and related neurodegenerative disorders.
Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
TLDR
It is found that APP751 mice have higher activity of p38 mitogen-activated protein kinase (p38 MAPK) in microglia, the main immune effector cells within the brain, and increased vulnerability to brain ischemia when compared with age-matched wild-type mice, and it is suggested that antiinflammatory compounds preventing activation of p 38 MAPK in microGlia may reduce neuronal vulnerability in AD.
Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
TLDR
This article verifies the predicted accumulation of soluble oligomers in AD frontal cortex and confirms the prediction that soluble oligomeric Aβ ligands are intrinsic to AD pathology, and validate their use in new approaches to therapeutic AD drugs and vaccines.
Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies
TLDR
Novel drugs that act at different levels of the neurodegenerative processes show great promise to reduce Neurodegeneration, and could help to prolong the time of unimpaired cognitive abilities of people who develop AD, allowing them to lead an independent life.
...
...